Crestor GALAXY Cardio Study Shoots For The Stars: 71,000 Patients To Recruit
Executive Summary
AstraZeneca's Crestor cardiovascular risk reduction program will require the recruitment of an additional 71,000 patients to ongoing clinical studies
You may also be interested in...
AstraZeneca Crestor Plan: Drop 80 Mg, Submit Lower-Dose Data In Q1
AstraZeneca's updated Crestor NDA will focus on doses of 40 mg and lower following a decision not to seek approval for the 80 mg strength of the cholesterol drug
AstraZeneca Crestor Post-NDA Studies Focusing On 40 Mg Dose
AstraZeneca's ongoing trials of Crestor are focusing on 40 mg as the maximum dose of the cholesterol-lowering drug
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011